Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Nguyen GH, Yassin AH, Magro CM. Unusual variants of intravascular malignant hematopoietic neoplasms: a report of 4 cases and review of the literature. Am J Dermatopathol. 2015;37(5):360-7.

Dyhdalo KS, Booth CN, Brainard JA, Croyle MC, Kolosiwsky AM, Goyal A, et al. Utility of GATA3, mammaglobin, GCDFP-15, and ER in the detection of intrathoracic metastatic breast carcinoma. J Am Soc Cytopathol. 2015;4(4):218-224.

Truong LD, Seshan SV. Enigma (partially) resolved: phospholipase A2 receptor is the cause of "idiopathic" membranous glomerulonephritis. Am J Physiol Renal Physiol. 2015;309(12):F1000-2.

Zhao Z, Chen C-, Rillahan CD, Shen R, Kitzing T, McNerney ME, et al. Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis. Nat Genet. 2015;47(5):539-43.

Arvanitakis Z, Brey RL, Rand JH, Schneider JA, Capuano AW, Yu L, et al. Relation of antiphospholipid antibodies to postmortem brain infarcts in older people. Circulation. 2015;131(2):182-9.

de la Calle C, Patil D, Wei JT, Scherr DS, Sokoll L, Chan DW, et al. Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men. J Urol. 2015;194(1):65-72.

Tyekucheva S, Martin NE, Stack EC, Wei W, Vathipadiekal V, Waldron L, et al. Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues. J Mol Diagn. 2015;17(4):374-81.

Wang B, Lee C-, Witt A, Thakkar A, Ince TA. Heat shock factor 1 induces cancer stem cell phenotype in breast cancer cell lines. Breast Cancer Res Treat. 2015;153(1):57-66.

DeSimone RA, Mitsios JV, Kucine N, Goss CA, Chadburn A, Cushing MM. Transfusion medicine illustrated. Hemoglobin C after a red blood cell transfusion for sickle cell disease. Transfusion. 2015;55(10):2304.

Iyengar NM, Morris PG, Zhou XK, Gucalp A, Giri D, Harbus MD, et al. Menopause is a determinant of breast adipose inflammation. Cancer Prev Res (Phila). 2015;8(5):349-58.